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Objective: Dose warping following deformable image
registration (DIR) has been proposed for interfractional
dose accumulation. Robust evaluation workflows are vital
to clinically implement such procedures. This study
demonstrates such a workflow and quantifies the accu-
racy of a commercial DIR algorithm for this purpose
under clinically realistic scenarios.
Methods: 12 head and neck (H&N) patient data sets were
used for this retrospective study. For each case, four
clinically relevant anatomical changes have been manu-
ally generated. Dose distributions were then calculated
on each artificially deformed image and warped back to
the original anatomy following DIR by a commercial
algorithm. Spatial registration was evaluated by quan-
titative comparison of the original and warped structure
sets, using conformity index and mean distance to
conformity (MDC) metrics. Dosimetric evaluation was
performed by quantitative comparison of the dose–
volume histograms generated for the calculated and
warped dose distributions, which should be identical
for the ideal “perfect” registration of mass-conserving
deformations.
Results: Spatial registration of the artificially deformed
image back to the planning CT was accurate (MDC range of
1–2 voxels or 1.2–2.4mm). Dosimetric discrepancies in-
troduced by the DIR were low (0.0260.03Gy per fraction
in clinically relevant dose metrics) with no statistically
significant difference found (Wilcoxon test, 0.6$p$0.2).
Conclusion: The reliability of CT-to-CT DIR-based dose
warping and image registration was demonstrated for
a commercial algorithm with H&N patient data.
Advances in knowledge: This study demonstrates awork-
flow for validation of dose warping following DIR that
could assist physicists and physicians in quantifying the
uncertainties associated with dose accumulation in
clinical scenarios.
Modern radiotherapy aims to move towards a personal-
ized treatment for each patient with cancer, requiring
reliable predictions of an individual’s response to a par-
ticular therapy and accurate monitoring of treatment
delivery, enabling adaptations to the treatment plan as
required. To date, typical radiotherapy practice involves
the preparation of a treatment plan based on an initial
high resolution CT scan of the anatomy to be treated.
However, since the treatment is optimized for the anat-
omy on planning CT (pCT), any changes in a patient’s
anatomy during the treatment course itself (which may
last for up to 8 weeks) could result in a suboptimal treat-
ment. Currently, to account for interfraction movements,
a low-resolution, low-dose CT image [typically cone beam
CT (CBCT) or mega-voltage CT (MVCT), although other
options exist] of the patient is often acquired prior to each
treatment (daily images). This is termed image-guided
radiotherapy (IGRT).1
In 1997, Yan et al2 proposed the concept of adaptive ra-
diotherapy (ART), suggesting the adaptation of the treat-
ment plan to account for interfraction anatomical
variations, based on these daily images. Such treatment
adaptations are sometimes currently employed in routine
clinical practice when signiﬁcant anatomical changes are
observed, such as substantial weight loss.3 State-of-the-art
ART, on the other hand, aims to regularly monitor the
treatment delivery and adapt when necessary (ofﬂine
ART)2 or even predict the result and alter it before the
treatment of that day (online ART).4 The ability to de-
termine the accumulated delivered dose to deforming
anatomy is of vital importance not only for ART but also
for the assessment and optimization of radiobiological
models,5 since without it, these models are informed by
less accurate estimates of delivered dose to each tissue or
partial tissue volume. However, certain limitations such as
inaccuracies in contour propagation and in reliable dose
accumulation currently prevent efﬁcient routine monitoring of
delivered dose throughout the treatment.
Deformable image registration (DIR) algorithms have been
proposed as a method for facilitating these processes. The ac-
curacy of DIR algorithms is therefore of critical importance and
has been the subject of investigation by several researchers, with
mechanical phantoms,6–13 patient images14–22 and digital
phantoms (i.e. patient images artiﬁcially deformed with known
deformations)10,11,23 being extensively used for DIR assessment.
An extension to these issues is the application of the underlying
anatomical deformations to a calculated dose distribution,
which is a necessary step in interfractional dose accumulation.
Such dose warping process involves the direct deformation of
a calculated dose distribution by applying the deformation
matrix estimated during DIR between two anatomical scans,
essentially warping the dose according to the reference anatomy.
Dose warping and deformable dose accumulation have been
employed in a number of clinical investigations, including a dose
feedback technique in ART frameworks,24 the assessment of
planning target volume (PTV) margins25 and the examination of
parotid gland dose–effect relationships,26 based on dose dis-
tributions recalculated on daily or weekly scans and the accu-
mulation on a single frame of reference. Consequently, quality
assurance and evaluation techniques have been investigated in
order to validate the applicability of this dose warping concept.
Previous work has investigated mathematical models to directly
convert DIR errors into dose-warping uncertainties, through
the use of patient images and mechanical or digital
phantoms,15,27–30 while a number of deformable dosimetric and
non-dosimetric gel phantoms have been produced enabling the
experimental evaluation of both DIR and dose warping.31–35
Even though some of these studies revealed promising results,
they have not convinced the radiotherapy community that these
uncertainties are adequately understood.36
In one such study, Yeo et al34 used a cylindrical deformable
dosimetric gel phantom for the experimental validation of dose
warping against actual three-dimensional (3D) measurements.
The warped and measured dose distributions revealed an
agreement of 3D g3%/3mm5 99.9%, after small deformations
(approximately 9mm), and g3%/3 mm5 96.7% after larger
deformations (approximately 20mm). The authors therefore
concluded that “dose-warping may be justiﬁed for small defor-
mations in particular and those that do not involve signiﬁcant
density changes”. On the other hand, Juang et al35 exposed
“substantial errors in a commercial DIR” used for dose-warping
evaluation, utilizing another 3D deformable dosimetric gel, re-
vealing a 3D g3%/3mm passing rate of 60%.
Such studies, and especially the use of deformable dosemeters
for the evaluation of dose warping, are very important as they
can reveal the 3D dosimetric impact owing to the uncertainties
of a given DIR algorithm. However, they possess three important
limitations: ﬁrst, typical physical dosimetric phantoms present
limited image complexity and would not assess the performance
limits of the DIR algorithm under evaluation in clinical sce-
narios. Second, plan delivery, intrinsic dosimetric and dose
reading uncertainties are present when using any type of dose-
meter in physical phantom measurements. The third limitation is
the fact that even where such approaches can offer high precision
dosimetric uncertainty evaluation, they cannot directly inform
users about the potential extent of those uncertainties in practical
clinical cases. All these issues will be addressed in this work.
In the present study, a workﬂow for the robust validation of DIR
and dose warping is presented, using patient images artiﬁcially
deformed with clinically realistic deformations and clinically
optimized Monte Carlo dose calculations of intensity-modulated
radiotherapy (IMRT) plans, quantifying both the spatial errors
in the deformable registration and their dosimetric impact when
applied to dose accumulation. In contrast to previously pro-
posed evaluation procedures, this method examines and reports
dose-warping uncertainties under clinically relevant scenarios.
Although the validation workﬂow is applicable for different
DIRs and clinical indications, it is here employed speciﬁcally for
the evaluation of a commercial software (OnQ rts®; Oncology
Systems Limited, Shropshire, UK) in head and neck (H&N)
cancer patient cases.
METHODS AND MATERIALS
Data selection
A total of 12 H&N patient data sets, consisting of a digital im-
aging and communications in medicine CT data set, associated
structure set (RTS), 6-MV IMRT plan (RTP) and corresponding
dose distribution (RTD), were randomly selected for this retro-
spective simulation study. Of the 12 patients used, 4 were treated
for unilateral and 8 for bilateral H&N cancer, while all treatment
plans were created using the Monte Carlo dose calculation al-
gorithm in Monaco® v. 3.20 (Elekta AB, Stockholm, Sweden)
treatment planning system (TPS). Treatment plans ranged in
complexity with 1–3 target volumes (1 PTV: n5 5; 2 PTVs:
n5 3; 3 PTVs: n5 4) while the prescribed dose per fraction
ranged from 2 to 3Gy.
Artificial deformations
For each patient, the pCT data set and structures (pRTS) were
transferred to ImSimQA v. 3.0.77 (Oncology Systems Limited,
Shropshire, UK), where four clinically realistic artiﬁcial deforma-
tions were manually introduced to create three “CTn” and “RTSn”
data sets (i.e. n referring to the nth artiﬁcial deformation in an
assumed interfractional dose accumulation workﬂow) in a process
previously demonstrated by Varadhan et al.23 ImSimQA employs
a radial basis function with thin-plate spline37 kernel function for
the application of global deformations, while to compact support
radial basis function38 is utilized for local deformations.
Backward (Def1) and forward (Def2) neck ﬂexion, weight loss
(Def3) and upward shoulder movement (Def4) have been ap-
plied to each data set using “global” or “local” deformations, as
summarized in Table 1 and shown in Figure 1. Artiﬁcial
deformations have been based on actual clinical observations
during image guidance at our institution (Queen Elizabeth
Hospital, Birmingham, UK) and visually inspected by a specialist
consultant and a specialist radiographer for clinical relevance.
Volume conservation in critical structures was quantitatively
investigated by comparing the original and deformed volumes.
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Deformable image registration and
dose-warping validation
The performance of the DIR algorithm has been evaluated with
the workﬂow shown in Figure 2. Following the application of
clinically realistic artiﬁcial deformations on the pCT images, the
new deformed images (CTn) were sent to Monaco TPS where
the original treatment plan was applied with identical conditions
(i.e. beam arrangement, isocentre, segment positions, monitor
units and monitor units per segment). The new dose calculated
(Dose_True) was considered the “true” dose, since this would be
the distribution delivered to the patient if the original plan was
to be applied on this anatomy. CTn with the associated structure
set (RTSn) and the calculated dose distribution (Dose_True)
were then loaded to OnQ rts together with pCT, where rigid
followed by DIR was performed. pCT was treated as the “ref-
erence”, and each CTn as the “moving” image (i.e. deforming
back to the original anatomy). OnQ utilizes an intensity-based
Demons algorithm39 for the execution of DIR between two CT
data sets. The CTn, RTSn and associated Dose_True were de-
formed accordingly by applying the deformation matrix calcu-
lated during DIR (dynamic vector ﬁeld). This resulted in warped
image (dCTn), structure set (dRTSn) and dose distribution
(Dose_Warp), which were then also copied to pCT.
A “perfect” DIR algorithm would be able to bring the artiﬁcially
deformed images and structures back to their original conﬁgu-
ration. Any deviations in these objects, therefore, would be
owing to the spatial inaccuracies of the DIR algorithm being
investigated. Comparison between the original (pRTS) and
warped (dRTSn) structure sets has been performed and the
registration result quantitatively evaluated utilizing the confor-
mity index (CI) and mean distance to conformity (MDC)
metrics:
CI is deﬁned as
CI5
Vn\Vp
Vn[Vp (1)
where Vn is the nth warped volume, and Vp is the original
planning volume of a certain structure.40 MDC is deﬁned as “the
average distance that all outlying points in the warped volume,
Vn, must be moved in order to achieve perfect conformity—
overlap—with the original volume, Vp,
40 and is measured in
units of distance (i.e. millimetre).
Furthermore, for the above situations in which mass of organs
under investigation is conserved, the same hypothetical “perfect”
DIR algorithm would result in agreement between the dose–
volume histogram (DVH) analyses of [Dose_Warp, pRTS] and
[Dose_True, dRTSn]. Differences in these values can therefore
be attributed to DIR inaccuracies and are evaluated by both
visual comparison of the DVHs and by quantitative differences
in clinically relevant dose metrics. The two dose distributions
were also compared with the original plan (Dose_Original) in
order to expose the dose delivery errors owing to the in-
troduction of artiﬁcial deformation on the original anatomy and
the ability of dose warping to estimate this effect. Evaluation was
herein performed utilizing the DVHs of brain, brainstem, lar-
ynx, spinal cord, contralateral parotid and the clinical target
volume (CTV). Spatial evaluation was performed by dose sub-
traction and 3D gamma analysis [computational environment
for radiotherapy research (CERR); Washington University,
St Louis, MO] with 2%/1mm criteria calculating the passing
ratio for all voxels receiving .20% of the maximum dose, for
Dose_Original, Dose_True and Dose_Warp.
Statistical analysis
The non-parametric two-sided Wilcoxon signed-rank test was
used for statistical analysis of dosimetric results, comparing the
mean absolute differences in mean, median, minimum or
maximum dose within certain structures as calculated by the
“Dose_True”, “Dose_Warp” and “Dose_Original”. Statistical
analysis was performed using R programming language v. 3.0.1
(R Core Team, Vienna, Austria; www.r-project.org) and was
carried out for each type of artiﬁcial deformation individually in
order to retain statistical independence.
RESULTS
Deformable image registration evaluation
The evaluation of the DIR algorithm’s performance under the four
artiﬁcial test conditions is shown in Figure 3. Figure 3a exposes the
respective mean values of MDC over the 12 patient data sets used.
With the exception of chiasm, the analysis of all volumes revealed
an MDC of 1.2–2.0mm. Considering the voxel size of the CTscans
used for this study (1.2mm in the x and y directions, and 2.0mm
in the z-direction), it is observed that the average registration
result is accurate to within 1–2 voxels.
Figure 3b shows the mean CI value for each artiﬁcial de-
formation for the data sets employed. Brainstem, contralateral
Table 1. The four types of clinically realistic artificial deformations applied to the planning CT images within ImSimQA v3.0.77
(Oncology Systems Limited, Shropshire, UK) to create the four “CTn”
Name Description Details
Def1 Forward neck ﬂexion
Chin and back of head moved by 10–15mm in opposite directions
(“global” deformation)
Def2 Backward neck ﬂexion
Chin and back of head moved by 10–15mm in opposite directions
(“global” deformation)
Def3 Weight loss Neck region shrank by 5mm (“local” deformation)
Def4 Upward shoulder movement Shoulders displaced by 10–15mm (“local” deformation)
Def1–4, the four artificial deformations applied.
Full paper: Validation of dose warping BJR
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parotid and mandible revealed mean CI values of 0.7 while cord,
brain, body and CTV had a CI of $0.8. Note that even though
CTV is not an anatomically deﬁnable structure, it was incorporated
in the DIR evaluation process as it would be used for the dosi-
metric analysis. Chiasm was the organ that revealed the lowest CI
values (0.4–0.2). As chiasm only covers 2–3 slices, an average
inaccuracy of 1–2 voxels in the z-direction results in very low CI.
Dose-warping validation
Examples of single fraction DVHs for the Dose_Original,
Dose_True and Dose_Warp for a typical patient in the four artiﬁcial
deformations are shown in Figure 4. The differences observed
between the Dose_Original and Dose_True curves clearly dem-
onstrate the expected dose delivery errors in the presence of
the artiﬁcial clinically realistic deformations. The warped dose
distribution revealed a generally good agreement with the
Dose_True. However, regions receiving low dose (i.e. ,20% of
prescribed dose) were occasionally underestimated, as observed
in brain, brainstem and spinal cord DVHs in Figure 4.
Figure 5 shows a comparison of the actual dose delivery change
owing to the presence of deformations (i.e. |Dose_True – Dose_
Original|), against the estimated change after warping back to
the original anatomy (i.e. |Dose_Warp – Dose_Original|), which is
subject to errors owing to DIR uncertainties. For a perfect DIR
algorithm and when mass is conserved in the regions under in-
vestigation, these values would be identical in all cases. This
comparison revealed good agreement (0.0260.03Gy) with no
statistically signiﬁcant differences (0.6$ p$ 0.2 in all cases). It is
observed that the minimum dose received by the CTV is occa-
sionally, but not signiﬁcantly (0.4$ p$ 0.3 in all cases), under-
estimated after dose warping as small spatial uncertainties have
bigger dosimetric effects in regions with steep dose gradients.
To further quantify the clinically relevant accuracy of the dose
warping process, Dose_Warp was compared against Dose_True
in terms of median, mean, maximum or minimum dose to the
brain, brainstem, spinal cord, contralateral parotid and CTV,
with the observed differences revealing no statistical signiﬁcance
(i.e. 0.5$ p$ 0.2 in all cases).
Even though non-statistically signiﬁcant throughout a total of 48
cases investigated, a number of substantial DIR and dose-warping
errors have been observed, as, for example, in Figure 4a; in this
instance, Dose_Warp reveals good agreement with Dose_True for
all organs except the brainstem, for which a difference of 0.35 and
0.25Gy in the median and maximum dose estimation was ob-
served, respectively, being the result of an outlier MDC error of
3.2mm in DIR.
Figure 6 shows examples of gamma maps between Dose_Original,
Dose_True and Dose_Warp. Gamma analysis of Dose_Original
vs Dose_True (Figure 6a) illustrates the differences in dose
distribution owing to the applied anatomical deformation.
Dose_Original vs Dose_Warp (Figure 6b) shows the same dif-
ferences after warping of Dose_True back to the original
anatomy, while Dose_True vs Dose_Warp (Figure 6c) illustrates
the effect of warping the recalculated dose distribution to the
reference anatomy. Subsequent review of the 3D gamma maps
conﬁrmed that the regions of largest disagreement are situated in
regions that combine dose gradient and displacement, as would
be expected, also demonstrated in the dose difference map
(Figure 6d). Gamma analysis of Dose_True vs Dose_Warp in the
forward neck ﬂexion simulation (Figure 6c) revealed greater
discrepancies at the chin and neck area, which experienced the
greatest displacement, while small differences were observed at the
inner body region where anatomical displacement was smaller.
Evaluation of artificial deformations
Artiﬁcial deformations have been conﬁrmed as clinically re-
alistic after visual inspection by a specialist consultant and
Figure 1. Examples of artificial deformations applied, with
dotted lines representing original contours, whereas normal
lines are showing new contours: (a) backward neck flexion
and (b) upward shoulder movement.
BJR YG Roussakis et al
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a specialist radiographer. Given the artiﬁcial deformations
being applied in this work (i.e. neck ﬂexion, weight loss
and shoulder movement), we would not expect structures
such as the brainstem, parotids and perhaps spinal cord to
be volumetrically changed. Reassuringly, quantitative com-
parison of the original and deformed structures revealed
perfect agreement in upward shoulder movement and weight
loss simulation cases and near perfect volumetric agree-
ment ($99%) in the forward/backward neck ﬂexion simu-
lation cases, for all structures under examination. An
investigation of the impact of this on the DVH analysis
employed herein is shown in the Appendix A. The magnitude
of the potential errors would not notably impact on the
above results.
Figure 2. Flow chart summarizing the dose-warping evaluation workflow. A planning CT (pCT) and the associated structure set
(pRTS) were imported in ImSimQA software v. 3.0.77 (Oncology Systems Limited, Shropshire, UK), where clinically realistic
deformations were applied to create four different artificial CT (CTn) and structure sets (RTSn)—that is, n refers to the nth
deformation. CTn and RTSn are then sent to Monaco treatment planning system where the original plan was applied and new dose
calculated (Dose_True). Rigid image registration (RIR) followed by deformable image registration (DIR) in OnQ rtsâ software
(Oncology Systems Limited) then warped CTn to pCT and the calculated deformation matrix was subsequently applied to RTSn and
Dose_True, resulting in a warped data set (dCTn, dRTSn and Dose_Warp). The pRTS and dRTSn are quantitatively compared
(conformity index and mean distance to conformity) for the evaluation of DIR. Then, dose–volume histograms (DVHs) are created from
Dose_True with RTSn (i.e. actual delivered dose) and Dose_Warp with pRTS (i.e. actual delivered dose warped to the reference anatomy).
DVHs were compared qualitatively (visual inspection of dose distributions) and quantitatively (comparison of certain measures, including
mean, median, maximum dose to each organ) for the evaluation of deformable dose accumulation (DDA). TPS, treatment planning system.
Full paper: Validation of dose warping BJR
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DISCUSSION
This study demonstrates a DIR algorithm validation workﬂow
for image registration and dose warping throughout fractionated
radiotherapy, while overcoming the four limitations of recent
studies that employed physical phantoms for the evaluation of
dose warping31–35 that were noted earlier: limited image com-
plexity, dose measurement accuracy and transfer of ﬁndings to
the clinical scenarios. The workﬂow has been used for the val-
idation of a commercial algorithm which, largely, demonstrated
accurate predictions of the actual dose distributions under four
clinically realistic deformation scenarios. All analysis was per-
formed for single fraction situations in order to simulate the
scenario of daily treatment monitoring that would be most
sensitive to any errors, as it excludes averaging effects from daily
anatomical variations. Recalculated dose distributions were
successfully warped to the reference anatomy [Dose_Warp,
pRTS] and revealed good agreement to the ground truth
[Dose_True, dRTSn], with the observed differences having no
statistical signiﬁcance (Wilcoxon test, 0.5$ p$ 0.2). However,
considerable registration and dose-warping errors have been
observed in a small number of cases, a ﬁnding that illustrates the
importance of such validation work as a means of highlighting
and understanding the presence and extent of errors in dose
accumulation processes and the need for visual inspection of
DIR results. These registration and dose-warping errors were
primarily observed in low contrast regions where DIR algo-
rithms are known to have inferior performance.
As the employed workﬂow included the comparison of DVH
metrics for the original and artiﬁcially deformed anatomies, any
volumetric differences between the structures could potentially
result in uncertainties. Volumetric comparison of the original and
deformed structures revealed $99% agreement, in the forward/
backward neck ﬂexion simulation cases. The potential “worst-case
scenario” dosimetric errors induced by this small mismatch in the
examined test cases were quantiﬁed as detailed in the Appendix A.
These “worst-case scenario” errors were shown to have very small
dosimetric consequences (e.g. 60.005Gy to the estimation of
median dose to the brainstem) and have been ignored.
There are three limitations to the present work. First, deform-
able registration and dose warping between two pCT quality
scans, as herein, is perhaps more robust than would be en-
countered clinically; even though some radiotherapy centres use
CT-on-rails for daily imaging, typical IGRT procedures employ
a range of alternative modalities, including CBCT, MVCT or
mega-voltage CBCT. These scans have lower image quality and
smaller ﬁeld-of-view than does CT, which may further
Figure 3. Evaluation analysis of deformable image registration (DIR) in the 12 patient cases under investigation, for the 4 artificial
deformations applied (Def1–4). (a) Average mean distance to conformity (MDC); (b) average conformity index (CI), for spinal cord, brain,
brainstem, chiasm, contralateral parotid (C. Parotid), larynx, mandible and clinical target volume (CTV). The error bars in both plots represent
the range of values observed, while the horizontal dashed lines in (a) represent the voxel size of the CT scans used in x, y and z direction.
BJR YG Roussakis et al
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compromise DIR performance. The validation workﬂow per-
formed herein can in principle be applied to artiﬁcially de-
formed images with added noise for the simulation of these
situations, an approach that is currently under investigation,
while the results of the present study could represent a “best-
case” scenario for the use of this algorithm in H&N cases. It
Figure 4. Dose–volume histograms comparing the clinically prescribed [Dose_Original, pRTS], recalculated on the artificial image
[Dose_True, dRTSn], and warped [Dose_Warp, pRTS] dose distributions, of artificial deformations 1–4 (a–d) for a single typical
patient. In situations where the mass of these organs is conserved, a “perfect” deformable image registration would show
agreement between [Dose_True, dRTSn] and [Dose_Warp, pRTS]. C. Parotid, contralateral parotid; CTV, clinical target volume.
Full paper: Validation of dose warping BJR
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Figure 5. The mean actual dose delivery change introduced by anatomical deformations, |Dose_True2Dose_Original|, against the
mean estimated dose change by deformable image registration-based dose warping |Dose_Warp2Dose_Original|, for the 12
patient cases investigated and the 4 artificial deformations applied (a–d), in spinal cord, brain, brainstem, contralateral parotid (C.
Parotid), larynx and clinical target volume (CTV). In situations where the mass of these organs is conserved, a “perfect” deformable
image registration would result in these values being the same for all situations. Max, maximum; Min, minimum.
BJR YG Roussakis et al
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should also be emphasized that the same workﬂow is applicable
to validate image registration and dose warping for any ana-
tomical site and any DIR algorithm, provided that the examined
structures undergo mass-conserving deformations.
Second, as the proposed workﬂow employs DVH analysis, the
mass and volume of organs under investigation must be con-
served. As previously observed, the volume of tumours and
certain organs occasionally decreases during the course of frac-
tionated H&N radiotherapy,41 a situation that was not simulated
herein. Nevertheless, this limitation is also present in other dose
warping evaluation workﬂows, such as the ones employing de-
formable dosimetric gel phantoms, while mass conservation is
an underlying assumption in many DIR algorithms.
The third limitation of the present work is the difﬁculty in quan-
titatively determining the spatial position of observed differences
using, for instance, gamma analysis as an evaluation test, since
the warped (Dose_Warp) and calculated (Dose_True) dose dis-
tributions are associated with different anatomies. A gamma anal-
ysis between them includes effects of both real anatomical change
and errors in deformable registration, the separation of which is
challenging. DVH analysis is applicable however, which is one of
the main examination tools used by physicians and physicists in
a clinical setting. This could be construed as an advantage of the
current evaluation workﬂow, providing clinically meaningful and
organ-speciﬁc uncertainty measures, a feature absent from most
validation work in the area. Besides, radiobiological analysis can be
applied to further assess the impact of DIR and dose-warping
uncertainties, which is beyond the scope of the present study.
As discussed previously, a number of studies have investigated
techniques for the evaluation of dose warping using deformable
dosimetric and non-dosimetric gel phantoms.31–35 Even though
such evaluation methodologies offer valuable advantages, such
as the ability to perform quantitative spatial dosimetric evalua-
tion, their ability to offer comprehensive conclusions under
clinical conditions is hindered by limited anatomical complexity,
dosimetric and dose-reading uncertainties and inability of
clinical interpretation of results. These techniques could there-
fore be employed as an initial dose warping evaluation workﬂow,
while the procedure described herein could provide further in-
sight and interpretation of results under clinical scenarios.
CONCLUSIONS
This retrospective simulation study demonstrates a workﬂow for
the validation of DIR and dose-warping performance of any DIR
algorithm in cases with mass-conserving deformations. Using
this workﬂow, with H&N patient images artiﬁcially deformed
with clinically realistic deformations, we have conﬁrmed that
OnQ rts successfully propagated the actual delivered dose to the
original planned anatomy by dose warping following CT-to-CT
DIR. Larger errors were occasionally observed, however, con-
ﬁrming that DIR performance should always be evaluated and
approved before proceeding to dose warping and accumulation
in the clinical setting.
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Figure 6. Three-dimensional gamma analysis (2%/1mm criteria) of (a) Dose_Original vs Dose_True, (b) Dose_Original vs
Dose_Warp, (c) Dose_True vs Dose_Warp and (d) dose subtraction Dose_Original2Dose_True, of a representative example after
forward neck flexion simulation.
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APPENDIX A
Analysis for volume conservation of critical structures during
the application of artiﬁcial deformations (forward and back-
ward neck ﬂexion) revealed an agreement of $99% for all
structures. An estimation of the potential mean “worst-case
scenario” dosimetric uncertainties owing to these volumetric
changes, in our test cases, was calculated using the following
equations:
emedian5
+
N
i51
maxðjD50%2D49:5%j;jD50%2D50:5%jÞ
N
emax5
+
N
i51
jDmax2D1%j
N
emin5
+
N
i51
jDmin2D99%j
N
where emedian, emax and emin is the estimated “worst-case sce-
nario” error in median, minimum and maximum dose to each
organ, respectively. Dmin is the minimum and Dmax the maxi-
mum dose delivered to each structure. D50%, D49.5%, D50.5%,
D99%, D1% is the dose received by 50%, 49.5%, 50.5%, 99% and
1% of each organ’s volume, respectively. N is the number of test
cases, which in this study was 12.
Estimated potential dosimetric uncertainties in the test cases
used, for the observed 1% difference in volume are summarized
in Table A1. It is assumed that the potential uncertainty in the
estimation of the mean dose to a certain organ owing to a 1%
change in volume would be less than that of the median dose
and was therefore not estimated.
Table A1. Estimated mean “worst-case scenario” errors in the calculation of median (emedian), maximum (emax) and minimum (emin)
dose to the organs and volumes under investigation
Region of interest emedian (Gy) emax (Gy) emin (Gy)
Brain 0.002 0.013 –
Brainstem 0.005 0.011 –
Spinal cord 0.004 0.010 –
Contralateral parotid 0.001 0.008 –
Planning target volume 0.001 – 0.020
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